Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. - Wikidata - awgldk - TriplyDB

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

http://www.wikidata.org/entity/Q37640910

about

Corticosteroids for the treatment of Duchenne muscular dystrophy Assisted standing for Duchenne muscular dystrophy Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophy Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials Current and emerging treatment strategies for Duchenne muscular dystrophy The importance of genetic diagnosis for Duchenne muscular dystrophy Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options Cardiac involvement in Duchenne and Becker muscular dystrophy Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy Splicing therapy for neuromuscular disease Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS Bone health and associated metabolic complications in neuromuscular diseases Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy Quality improvement in neurology: muscular dystrophy quality measures Duchenne muscular dystrophy: the management of scoliosis Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture A protocol to develop clinical guidelines for inclusion-body myositis The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repair Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial.Functional Neuronal Differentiation of Injury-Induced Muscle-Derived Stem Cell-Like Cells with Therapeutic Implications.Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials Analysis of Pulmonary Function Test in Korean Patients With Duchenne Muscular Dystrophy: Comparison of Foreign and Korean Reference Data.Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor.Decreased inward rectifier potassium current IK1 in dystrophin-deficient ventricular cardiomyocytes.Engaging Patients and Caregivers Managing Rare Diseases to Improve the Methods of Clinical Guideline Development: A Research Protocol.Limb-girdle and congenital muscular dystrophies: current diagnostics, management, and emerging technologies.Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy.Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.The burden of Duchenne muscular dystrophy: an international, cross-sectional study.

P2860

Q24185788-C5641000-FA4A-4482-BC1D-A148995584E8 Q24187775-C64BCCE8-CF34-44D8-9257-8E281F73DA49 Q24198280-3D784DB7-2185-4449-8EFF-3C940D02452A Q24306601-87F61C45-6A97-4F86-B317-CB72C478BBF5 Q26741409-4285EFC9-FEBC-4A4E-BBAA-D5CADE30F26B Q26741535-EFD30DE3-B561-407F-98B8-D679B93A3197 Q26769701-88C99C75-060F-494F-A207-5EE1F67C1590 Q26777206-94125D87-435A-425F-8AE5-FB96A36F1F58 Q26785627-B270AD66-DAE7-4B49-9321-DD8AD9ADBA37 Q26801616-5A5E1C8B-784C-45EE-BC4A-1FB94A1FB759 Q27006945-EFEABEA1-0F31-4E87-90D6-6AA92D5FBD4C Q27009581-2C08A700-F530-483E-B60C-4B74F0E8DD2C Q27021649-BF474950-6D68-4940-87FD-2D6FDD89C9F1 Q27025688-C1D38D91-AECF-430E-98C0-1DF4C7BEEB8B Q27318308-CFA3D451-4977-4CDB-AFF7-121798AB09BE Q27348818-F86D9349-791B-4172-9AF1-8569A64E2C09 Q28067793-13479270-BD8F-4F23-B149-5A59B60B0E87 Q28072269-39FC04EA-B211-4E4C-AB91-C1AFA0CB87A6 Q28077552-370EE9E7-9FCB-4DAE-9AFE-051A4C6E5223 Q28088277-90254CF2-7FCA-4643-A0B8-9786919B687A Q28484851-4FADDBFF-0B9C-4398-B06E-5857BDF836FD Q28544401-76410770-4B34-4992-AAE0-A38B14DD64A4 Q28741359-B8A1B25D-F26E-4EF8-80D9-43FC7099F197 Q30000808-16DE9294-5DA1-48AD-A8C3-2AEF11E2DBEC Q30557216-8782CD39-055D-421F-9113-413E00EE4FD8 Q30665063-6D4E557E-FD50-4092-8137-6087DF081A43 Q30842938-C8749256-BD4E-4853-8009-B4787C352345 Q30850601-5E8F4AD1-BDFE-407F-B108-EC222ADF178F Q31131975-B1790AD4-54FC-44E5-844D-FA491C2D6B69 Q31142494-CA455D25-6793-4D67-BC95-9435BAF811EC Q33570741-BE9CD6E5-60AA-437D-836E-82A3123BF343 Q33584881-055B50C7-6C8D-49F1-9527-352236B6DD5D Q33676797-3B80F868-08D9-4EA4-86AC-5FCF517EE27D Q33837536-050B51AA-CEF2-48BB-AF37-C1DD323EE33C Q33844719-F2E1635E-E42D-4996-A7E6-6E4E30C47965 Q33860859-ED1E6236-5A8B-4F9E-A3E2-1151BBBB46D1 Q33925571-FE939E34-DD73-4529-A058-4F2AEEF1BBEB Q33987140-3D26B9E4-DDAC-4662-82AA-5FA50085B0A1 Q33991780-80B5459B-AAE6-40F8-A823-1EFF3BA6AE96 Q34079312-FD8B855A-4ED6-46CB-8007-35D308E5DAC2

P2860

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

http://www.wikidata.org/entity/Q37640910

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Diagnosis and management of Du ...... ion of multidisciplinary care.

@en

Diagnosis and management of Du ...... ion of multidisciplinary care.

@nl

type

label

Diagnosis and management of Du ...... ion of multidisciplinary care.

@en

Diagnosis and management of Du ...... ion of multidisciplinary care.

@nl

prefLabel

Diagnosis and management of Du ...... ion of multidisciplinary care.

@en

Diagnosis and management of Du ...... ion of multidisciplinary care.

@nl

P1433

Q37640910-E3F90F32-0055-4BBB-BF84-58F0BFB8EBD2

P1476

Q37640910-6DF77F38-D6E3-4304-95D9-0010FB805E0B

P2093

Q37640910-372331E9-A2A2-4201-A0F4-1969B0C64B3E

Q37640910-51F0C895-1B8C-4985-9D97-1482DBEBF666

Q37640910-6338D904-8D74-48EC-920D-208B84B93E8F

Q37640910-7FC568C1-F5C0-4F20-96F1-A22405236B80

Q37640910-9462AE58-443B-4859-9E64-DB8F9273B17B

Q37640910-995DC270-05A9-4F4E-9747-85101CBF9701

Q37640910-A3D5A9CD-0723-4951-8202-55EBFE12EC6F

Q37640910-A6742BA0-0C3C-4DE3-8A1D-8706C26CBF5C

Q37640910-A7E681A1-F481-4BDB-8928-E750EDFCC81D

Q37640910-B7564B88-6693-41E4-832C-669AD94CF01C

P304

Q37640910-7AAEB1A6-66E4-4295-8FFD-07ADEECC7A88

P31

Q37640910-93264F1E-440E-47B9-8237-828FD75918E2

P356

Q37640910-D2DA2E66-841E-4B28-AC5D-2A42325DD66C

P433

Q37640910-B9F6A56A-D792-4768-9094-17ACF3E2CC5E

P478

Q37640910-CD5AD0F7-8D02-48DB-86AC-82257910D080

P50

Q37640910-2DD58C9D-07B0-4F0B-9FBF-CC2C543D0196

Q37640910-3D41BCCA-BF32-4476-9625-1D1FEA7340D0

Q37640910-650DD1BD-EC18-4A96-97A6-5F4E959EC56E

P577

Q37640910-041E7A7C-5A10-426F-BDF9-062829A16BE4

P698

Q37640910-F241683A-46D9-48CB-B2AE-E8DA8054A0F4

P921

Q37640910-27afc465-ae09-4dbc-b885-63e07f52ed7c

P356

S1474-4422(09)70272-8

P1433

Lancet Neurology

P1476

Diagnosis and management of Du ...... ion of multidisciplinary care.

@en

P2093

Ajay Kaul

http://www.w3.org/2001/XMLSchema#string

Carolyn Constantin

http://www.w3.org/2001/XMLSchema#string

DMD Care Considerations Working Group

http://www.w3.org/2001/XMLSchema#string

Frederic Shapiro

http://www.w3.org/2001/XMLSchema#string

James Poysky

http://www.w3.org/2001/XMLSchema#string

Jean Tomezsko

http://www.w3.org/2001/XMLSchema#string

Katharine Bushby

http://www.w3.org/2001/XMLSchema#string

Kathi Kinnett

http://www.w3.org/2001/XMLSchema#string

Linda Cripe

http://www.w3.org/2001/XMLSchema#string

Paula R Clemens

http://www.w3.org/2001/XMLSchema#string

P304

177-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(09)70272-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Craig M. McDonald

David J Birnkrant

P577

2009-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19945914

http://www.w3.org/2001/XMLSchema#string

P921